Takeda in talks for $12-billion acquisition

year that an IPO this year was highly unlikely. Last year, Nycomed bought a majority stake in a Chinese pharmaceutical company, underscoring its focus on emerging markets and Western manufacturers' hunger to boost their presence in the country. It paid...